Stay updated on Branaplam Safety in Early Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.

Latest updates to the Branaplam Safety in Early Huntington's Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference2%

- Check27 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations related to Huntington's disease, as well as new publications from PubMed. Notably, the terminology has been standardized, with 'Huntington's disease' being used consistently.SummaryDifference3%

- Check70 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Branaplam Safety in Early Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.